Europe Fluorescent Immunoassay Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product Type (ELISA, Rapid Lateral Flow Immunoassay, and Others), Application (Infectious Diseases, Oncology, Cardiovascular Diseases, and Others), and End User (Hospitals & Clinics, Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Others) 

No. of Pages: 168    |    Report Code: BMIRE00025661    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Fluorescent Immunoassay Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Europe Fluorescent Immunoassay Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Europe Fluorescent Immunoassay Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Growing prevalence of infectious and chronic diseases
5.2 Market Opportunities
  • 5.2.1 Technological Developments such as automated systems
5.3 Future Trends
  • 5.3.1 Emerging Markets
5.4 Impact of Drivers and Restraints

6. Europe Fluorescent Immunoassay Market Regional Analysis

6.1 Europe Fluorescent Immunoassay Market Overview
6.2 Europe Fluorescent Immunoassay Market Revenue 2019-2028 (US$ Million)
6.3 Europe Fluorescent Immunoassay Market Forecast Analysis

7. Europe Fluorescent Immunoassay Market Analysis – by Product Type

7.1 ELISA
  • 7.1.1 Overview
  • 7.1.2 ELISA: Europe Fluorescent Immunoassay Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Rapid Lateral Flow Immunoassay
  • 7.2.1 Overview
  • 7.2.2 Rapid Lateral Flow Immunoassay: Europe Fluorescent Immunoassay Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Fluorescent Immunoassay Market Analysis – by Application

8.1 Infectious Diseases
  • 8.1.1 Overview
  • 8.1.2 Infectious Diseases: Europe Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Oncology
  • 8.2.1 Overview
  • 8.2.2 Oncology: Europe Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Cardiovascular Diseases
  • 8.3.1 Overview
  • 8.3.2 Cardiovascular Diseases: Europe Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Fluorescent Immunoassay Market Analysis – by End User

9.1 Hospitals & Clinics
  • 9.1.1 Overview
  • 9.1.2 Cardiovascular Diseases: Europe Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Diagnostic Centers
  • 9.2.1 Overview
  • 9.2.2 Cardiovascular Diseases: Europe Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Pharmaceutical & Biotechnology Companies
  • 9.3.1 Overview
  • 9.3.2 Cardiovascular Diseases: Europe Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Academic & Research Institutes
  • 9.4.1 Overview
  • 9.4.2 Cardiovascular Diseases: Europe Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (US$ Million)

10. Europe Fluorescent Immunoassay Market – Europe Analysis

10.1 Europe
  • 10.1.1 Europe Fluorescent Immunoassay Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.1.1.1 Europe Fluorescent Immunoassay Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 UK: Europe Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 UK: Europe Fluorescent Immunoassay Market Breakdown, by Product Type
    • 10.1.1.1.2 UK: Europe Fluorescent Immunoassay Market Breakdown, by Application
    • 10.1.1.1.3 UK: Europe Fluorescent Immunoassay Market Breakdown, by End User
  • 10.1.1.2 Germany: Europe Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Germany: Europe Fluorescent Immunoassay Market Breakdown, by Product Type
    • 10.1.1.2.2 Germany: Europe Fluorescent Immunoassay Market Breakdown, by Application
    • 10.1.1.2.3 Germany: Europe Fluorescent Immunoassay Market Breakdown, by End User
  • 10.1.1.3 France: Europe Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 France: Europe Fluorescent Immunoassay Market Breakdown, by Product Type
    • 10.1.1.3.2 France: Europe Fluorescent Immunoassay Market Breakdown, by Application
    • 10.1.1.3.3 France: Europe Fluorescent Immunoassay Market Breakdown, by End User
  • 10.1.1.4 Russia: Europe Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.4.1 Russia: Europe Fluorescent Immunoassay Market Breakdown, by Product Type
    • 10.1.1.4.2 Russia: Europe Fluorescent Immunoassay Market Breakdown, by Application
    • 10.1.1.4.3 Russia: Europe Fluorescent Immunoassay Market Breakdown, by End User
  • 10.1.1.5 Italy: Europe Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.5.1 Italy: Europe Fluorescent Immunoassay Market Breakdown, by Product Type
    • 10.1.1.5.2 Italy: Europe Fluorescent Immunoassay Market Breakdown, by Application
    • 10.1.1.5.3 Italy: Europe Fluorescent Immunoassay Market Breakdown, by End User
  • 10.1.1.6 Rest of Europe: Europe Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.6.1 Rest of Europe: Europe Fluorescent Immunoassay Market Breakdown, by Product Type
    • 10.1.1.6.2 Rest of Europe: Europe Fluorescent Immunoassay Market Breakdown, by Application
    • 10.1.1.6.3 Rest of Europe: Europe Fluorescent Immunoassay Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Europe Fluorescent Immunoassay Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Abbott
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 BD
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 bioMerieux SA
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Danaher
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 F. Hoffmann-La Roche Ltd.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Ortho Clinical Diagnostics Holdings plc
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Quidel Corporation
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Siemens AG
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Sysmex Corporation
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Thermo Fisher Scientific Inc.
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - Europe Fluorescent Immunoassay Market

  1. Abbott
  2. BD
  3. bioMerieux SA
  4. Danaher
  5. F. Hoffmann-La Roche Ltd.
  6. Ortho Clinical Diagnostics Holdings plc
  7. Quidel Corporation
  8. Siemens AG
  9. Sysmex Corporation
  10. Thermo Fisher Scientific Inc.
europe-fluorescent-immunoassay-market